Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
WNT SIGNALING PATHWAY |
49 |
351 |
4.009e-67 |
1.865e-63 |
2 |
CANONICAL WNT SIGNALING PATHWAY |
26 |
95 |
2.676e-42 |
6.226e-39 |
3 |
REGULATION OF WNT SIGNALING PATHWAY |
29 |
310 |
9.399e-33 |
1.458e-29 |
4 |
NON CANONICAL WNT SIGNALING PATHWAY |
22 |
140 |
7.149e-30 |
8.316e-27 |
5 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
21 |
197 |
8.232e-25 |
7.661e-22 |
6 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
42 |
1929 |
9.667e-23 |
7.496e-20 |
7 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
37 |
1492 |
1.551e-21 |
1.031e-18 |
8 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
38 |
1672 |
7.168e-21 |
4.169e-18 |
9 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
12 |
39 |
1.835e-20 |
9.488e-18 |
10 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
19 |
236 |
4.048e-20 |
1.883e-17 |
11 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
37 |
1710 |
1.594e-19 |
6.743e-17 |
12 |
POSITIVE REGULATION OF GENE EXPRESSION |
37 |
1733 |
2.499e-19 |
9.69e-17 |
13 |
PATTERN SPECIFICATION PROCESS |
22 |
418 |
3.088e-19 |
1.105e-16 |
14 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
30 |
1021 |
3.742e-19 |
1.244e-16 |
15 |
EPITHELIUM DEVELOPMENT |
29 |
945 |
5.45e-19 |
1.691e-16 |
16 |
CELL PROLIFERATION |
25 |
672 |
2.971e-18 |
8.64e-16 |
17 |
TISSUE DEVELOPMENT |
34 |
1518 |
3.21e-18 |
8.786e-16 |
18 |
ORGAN MORPHOGENESIS |
27 |
841 |
4.024e-18 |
1.04e-15 |
19 |
POSITIVE REGULATION OF CELL COMMUNICATION |
34 |
1532 |
4.261e-18 |
1.044e-15 |
20 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
30 |
1135 |
7.081e-18 |
1.647e-15 |
21 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
32 |
1360 |
1.131e-17 |
2.506e-15 |
22 |
TUBE MORPHOGENESIS |
19 |
323 |
1.508e-17 |
3.189e-15 |
23 |
REGULATION OF CELL DIFFERENTIATION |
33 |
1492 |
1.81e-17 |
3.661e-15 |
24 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
30 |
1192 |
2.728e-17 |
5.288e-15 |
25 |
MORPHOGENESIS OF AN EPITHELIUM |
20 |
400 |
4.479e-17 |
8.337e-15 |
26 |
TISSUE MORPHOGENESIS |
22 |
533 |
5.352e-17 |
9.578e-15 |
27 |
EMBRYONIC MORPHOGENESIS |
22 |
539 |
6.768e-17 |
1.166e-14 |
28 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
35 |
1805 |
7.691e-17 |
1.278e-14 |
29 |
TUBE DEVELOPMENT |
22 |
552 |
1.115e-16 |
1.789e-14 |
30 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
35 |
1848 |
1.601e-16 |
2.404e-14 |
31 |
REGIONALIZATION |
18 |
311 |
1.583e-16 |
2.404e-14 |
32 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
33 |
1618 |
2.008e-16 |
2.92e-14 |
33 |
EMBRYO DEVELOPMENT |
26 |
894 |
2.15e-16 |
3.021e-14 |
34 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
31 |
1395 |
2.207e-16 |
3.021e-14 |
35 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
27 |
1036 |
7.361e-16 |
9.515e-14 |
36 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
27 |
1036 |
7.361e-16 |
9.515e-14 |
37 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
28 |
1142 |
8.6e-16 |
1.082e-13 |
38 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
14 |
162 |
1.937e-15 |
2.371e-13 |
39 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
18 |
365 |
2.608e-15 |
3.111e-13 |
40 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
33 |
1791 |
3.927e-15 |
4.569e-13 |
41 |
PROTEIN PHOSPHORYLATION |
25 |
944 |
8.082e-15 |
9.172e-13 |
42 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
27 |
1152 |
9.911e-15 |
1.072e-12 |
43 |
CELL FATE COMMITMENT |
15 |
227 |
9.742e-15 |
1.072e-12 |
44 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
25 |
957 |
1.104e-14 |
1.167e-12 |
45 |
BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY |
8 |
22 |
1.132e-14 |
1.171e-12 |
46 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
29 |
1381 |
1.26e-14 |
1.274e-12 |
47 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
12 |
110 |
1.328e-14 |
1.315e-12 |
48 |
NEURON DIFFERENTIATION |
24 |
874 |
1.444e-14 |
1.4e-12 |
49 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
23 |
788 |
1.609e-14 |
1.497e-12 |
50 |
CIRCULATORY SYSTEM DEVELOPMENT |
23 |
788 |
1.609e-14 |
1.497e-12 |
51 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
32 |
1784 |
2.628e-14 |
2.398e-12 |
52 |
AXIS SPECIFICATION |
11 |
90 |
4.959e-14 |
4.437e-12 |
53 |
REGULATION OF RESPONSE TO STRESS |
29 |
1468 |
6.049e-14 |
5.311e-12 |
54 |
REGULATION OF CELL CYCLE |
24 |
949 |
8.726e-14 |
7.519e-12 |
55 |
REGULATION OF CELL PROLIFERATION |
29 |
1496 |
9.795e-14 |
8.287e-12 |
56 |
NEUROGENESIS |
28 |
1402 |
1.467e-13 |
1.219e-11 |
57 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
16 |
337 |
1.979e-13 |
1.616e-11 |
58 |
INTRACELLULAR SIGNAL TRANSDUCTION |
29 |
1572 |
3.442e-13 |
2.761e-11 |
59 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
22 |
823 |
3.975e-13 |
3.135e-11 |
60 |
CELL ACTIVATION |
19 |
568 |
4.307e-13 |
3.34e-11 |
61 |
SENSORY ORGAN DEVELOPMENT |
18 |
493 |
4.507e-13 |
3.438e-11 |
62 |
REGULATION OF CELL DEATH |
28 |
1472 |
4.852e-13 |
3.641e-11 |
63 |
REGULATION OF ORGAN MORPHOGENESIS |
14 |
242 |
5.096e-13 |
3.764e-11 |
64 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
13 |
194 |
5.705e-13 |
4.148e-11 |
65 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
20 |
691 |
1.353e-12 |
9.683e-11 |
66 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
15 |
323 |
1.674e-12 |
1.18e-10 |
67 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
16 |
393 |
2.067e-12 |
1.436e-10 |
68 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
21 |
801 |
2.204e-12 |
1.508e-10 |
69 |
PHOSPHORYLATION |
25 |
1228 |
2.918e-12 |
1.968e-10 |
70 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
18 |
554 |
3.192e-12 |
2.122e-10 |
71 |
BETA CATENIN TCF COMPLEX ASSEMBLY |
8 |
43 |
4.808e-12 |
3.151e-10 |
72 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
28 |
1656 |
8.376e-12 |
5.413e-10 |
73 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
12 |
197 |
1.466e-11 |
9.345e-10 |
74 |
RESPONSE TO ENDOGENOUS STIMULUS |
26 |
1450 |
1.645e-11 |
1.034e-09 |
75 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
30 |
1977 |
1.725e-11 |
1.056e-09 |
76 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
11 |
152 |
1.704e-11 |
1.056e-09 |
77 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
20 |
799 |
1.884e-11 |
1.139e-09 |
78 |
REGULATION OF JNK CASCADE |
11 |
159 |
2.782e-11 |
1.66e-09 |
79 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
17 |
552 |
3.236e-11 |
1.906e-09 |
80 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
11 |
162 |
3.408e-11 |
1.982e-09 |
81 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
26 |
1518 |
4.559e-11 |
2.619e-09 |
82 |
EMBRYONIC PATTERN SPECIFICATION |
8 |
58 |
6.065e-11 |
3.442e-09 |
83 |
DORSAL VENTRAL PATTERN FORMATION |
9 |
91 |
7.862e-11 |
4.408e-09 |
84 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
20 |
876 |
9.723e-11 |
5.386e-09 |
85 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
10 |
135 |
1.194e-10 |
6.539e-09 |
86 |
RESPONSE TO LIPID |
20 |
888 |
1.237e-10 |
6.692e-09 |
87 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
21 |
1004 |
1.504e-10 |
8.042e-09 |
88 |
CELLULAR RESPONSE TO RETINOIC ACID |
8 |
65 |
1.563e-10 |
8.263e-09 |
89 |
FC EPSILON RECEPTOR SIGNALING PATHWAY |
10 |
142 |
1.971e-10 |
1.031e-08 |
90 |
HEART DEVELOPMENT |
15 |
466 |
2.949e-10 |
1.525e-08 |
91 |
NEURAL TUBE DEVELOPMENT |
10 |
149 |
3.17e-10 |
1.621e-08 |
92 |
REGULATION OF CELL MORPHOGENESIS |
16 |
552 |
3.235e-10 |
1.636e-08 |
93 |
RESPONSE TO RETINOIC ACID |
9 |
107 |
3.422e-10 |
1.712e-08 |
94 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
18 |
740 |
3.647e-10 |
1.805e-08 |
95 |
REGULATION OF PROTEIN LOCALIZATION |
20 |
950 |
4.049e-10 |
1.983e-08 |
96 |
RESPONSE TO WOUNDING |
16 |
563 |
4.312e-10 |
2.09e-08 |
97 |
CELL DEVELOPMENT |
24 |
1426 |
4.585e-10 |
2.199e-08 |
98 |
GASTRULATION |
10 |
155 |
4.674e-10 |
2.219e-08 |
99 |
REGULATION OF MAPK CASCADE |
17 |
660 |
5.113e-10 |
2.379e-08 |
100 |
EMBRYONIC ORGAN DEVELOPMENT |
14 |
406 |
5.079e-10 |
2.379e-08 |
101 |
REGULATION OF EMBRYONIC DEVELOPMENT |
9 |
114 |
6.053e-10 |
2.788e-08 |
102 |
NEGATIVE REGULATION OF CELL DEATH |
19 |
872 |
6.86e-10 |
3.129e-08 |
103 |
EMBRYONIC ORGAN MORPHOGENESIS |
12 |
279 |
8.216e-10 |
3.712e-08 |
104 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
7 |
50 |
9.099e-10 |
4.071e-08 |
105 |
REGULATION OF BINDING |
12 |
283 |
9.661e-10 |
4.281e-08 |
106 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
11 |
228 |
1.321e-09 |
5.799e-08 |
107 |
POSITIVE REGULATION OF CELL PROLIFERATION |
18 |
814 |
1.663e-09 |
7.233e-08 |
108 |
RHYTHMIC PROCESS |
12 |
298 |
1.735e-09 |
7.476e-08 |
109 |
REGULATION OF IMMUNE SYSTEM PROCESS |
23 |
1403 |
1.955e-09 |
8.347e-08 |
110 |
SEGMENTATION |
8 |
89 |
2.029e-09 |
8.582e-08 |
111 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
7 |
56 |
2.074e-09 |
8.692e-08 |
112 |
REGULATION OF CATABOLIC PROCESS |
17 |
731 |
2.402e-09 |
9.979e-08 |
113 |
REGULATION OF PROTEIN TARGETING |
12 |
307 |
2.428e-09 |
9.999e-08 |
114 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
9 |
134 |
2.559e-09 |
1.027e-07 |
115 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
13 |
381 |
2.557e-09 |
1.027e-07 |
116 |
REGULATION OF CELL DEVELOPMENT |
18 |
836 |
2.532e-09 |
1.027e-07 |
117 |
REGULATION OF TRANSFERASE ACTIVITY |
19 |
946 |
2.64e-09 |
1.05e-07 |
118 |
EMBRYONIC AXIS SPECIFICATION |
6 |
33 |
2.946e-09 |
1.162e-07 |
119 |
POSITIVE REGULATION OF MAPK CASCADE |
14 |
470 |
3.35e-09 |
1.299e-07 |
120 |
WOUND HEALING |
14 |
470 |
3.35e-09 |
1.299e-07 |
121 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
14 |
472 |
3.536e-09 |
1.36e-07 |
122 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
34 |
3.567e-09 |
1.36e-07 |
123 |
REGULATION OF IMMUNE RESPONSE |
18 |
858 |
3.807e-09 |
1.439e-07 |
124 |
RESPONSE TO GROWTH FACTOR |
14 |
475 |
3.834e-09 |
1.439e-07 |
125 |
SOMITOGENESIS |
7 |
62 |
4.316e-09 |
1.606e-07 |
126 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
13 |
406 |
5.482e-09 |
2.025e-07 |
127 |
REGULATION OF KINASE ACTIVITY |
17 |
776 |
5.866e-09 |
2.149e-07 |
128 |
FC RECEPTOR SIGNALING PATHWAY |
10 |
206 |
7.39e-09 |
2.685e-07 |
129 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
19 |
1008 |
7.443e-09 |
2.685e-07 |
130 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
23 |
1517 |
8.674e-09 |
3.105e-07 |
131 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
11 |
274 |
9.019e-09 |
3.203e-07 |
132 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
8 |
109 |
1.025e-08 |
3.587e-07 |
133 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
14 |
513 |
1.018e-08 |
3.587e-07 |
134 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
18 |
917 |
1.071e-08 |
3.721e-07 |
135 |
REGULATION OF CELLULAR LOCALIZATION |
21 |
1277 |
1.126e-08 |
3.852e-07 |
136 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
15 |
609 |
1.121e-08 |
3.852e-07 |
137 |
DORSAL VENTRAL AXIS SPECIFICATION |
5 |
20 |
1.173e-08 |
3.984e-07 |
138 |
REGULATION OF PROTEOLYSIS |
16 |
711 |
1.213e-08 |
4.089e-07 |
139 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
15 |
616 |
1.305e-08 |
4.368e-07 |
140 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
10 |
220 |
1.385e-08 |
4.604e-07 |
141 |
CELLULAR RESPONSE TO LIPID |
13 |
457 |
2.232e-08 |
7.263e-07 |
142 |
UROGENITAL SYSTEM DEVELOPMENT |
11 |
299 |
2.219e-08 |
7.263e-07 |
143 |
SOMITE DEVELOPMENT |
7 |
78 |
2.206e-08 |
7.263e-07 |
144 |
SINGLE ORGANISM CELL ADHESION |
13 |
459 |
2.35e-08 |
7.593e-07 |
145 |
KIDNEY EPITHELIUM DEVELOPMENT |
8 |
125 |
3.02e-08 |
9.688e-07 |
146 |
SENSORY ORGAN MORPHOGENESIS |
10 |
239 |
3.04e-08 |
9.688e-07 |
147 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
6 |
48 |
3.117e-08 |
9.799e-07 |
148 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
13 |
470 |
3.103e-08 |
9.799e-07 |
149 |
NEGATIVE REGULATION OF GENE EXPRESSION |
22 |
1493 |
3.35e-08 |
1.046e-06 |
150 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
16 |
767 |
3.492e-08 |
1.083e-06 |
151 |
REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS |
9 |
181 |
3.557e-08 |
1.096e-06 |
152 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
16 |
771 |
3.753e-08 |
1.149e-06 |
153 |
REGULATION OF PROTEIN IMPORT |
9 |
183 |
3.912e-08 |
1.19e-06 |
154 |
PALATE DEVELOPMENT |
7 |
85 |
4.032e-08 |
1.218e-06 |
155 |
REGULATION OF CYTOPLASMIC TRANSPORT |
13 |
481 |
4.069e-08 |
1.221e-06 |
156 |
POSITIVE REGULATION OF KINASE ACTIVITY |
13 |
482 |
4.169e-08 |
1.243e-06 |
157 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
8 |
131 |
4.359e-08 |
1.292e-06 |
158 |
MESENCHYME DEVELOPMENT |
9 |
190 |
5.406e-08 |
1.572e-06 |
159 |
STEM CELL DIFFERENTIATION |
9 |
190 |
5.406e-08 |
1.572e-06 |
160 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
190 |
5.406e-08 |
1.572e-06 |
161 |
EPITHELIAL CELL PROLIFERATION |
7 |
89 |
5.559e-08 |
1.607e-06 |
162 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
12 |
408 |
5.702e-08 |
1.638e-06 |
163 |
MESONEPHROS DEVELOPMENT |
7 |
90 |
6.01e-08 |
1.715e-06 |
164 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
10 |
258 |
6.246e-08 |
1.772e-06 |
165 |
POSITIVE REGULATION OF CELL CYCLE |
11 |
332 |
6.456e-08 |
1.821e-06 |
166 |
BIOLOGICAL ADHESION |
18 |
1032 |
6.518e-08 |
1.827e-06 |
167 |
DEVELOPMENTAL GROWTH |
11 |
333 |
6.656e-08 |
1.854e-06 |
168 |
INNER EAR MORPHOGENESIS |
7 |
92 |
7.003e-08 |
1.94e-06 |
169 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
10 |
263 |
7.476e-08 |
2.058e-06 |
170 |
POSITIVE REGULATION OF CELL DEATH |
14 |
605 |
7.958e-08 |
2.178e-06 |
171 |
NEURAL TUBE FORMATION |
7 |
94 |
8.131e-08 |
2.213e-06 |
172 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
13 |
514 |
8.806e-08 |
2.382e-06 |
173 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
8 |
144 |
9.104e-08 |
2.449e-06 |
174 |
STEM CELL PROLIFERATION |
6 |
60 |
1.225e-07 |
3.277e-06 |
175 |
CELL CYCLE PROCESS |
18 |
1081 |
1.308e-07 |
3.477e-06 |
176 |
HEART MORPHOGENESIS |
9 |
212 |
1.381e-07 |
3.65e-06 |
177 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
10 |
282 |
1.432e-07 |
3.766e-06 |
178 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
11 |
360 |
1.461e-07 |
3.82e-06 |
179 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
10 |
285 |
1.58e-07 |
4.108e-06 |
180 |
RESPONSE TO NITROGEN COMPOUND |
16 |
859 |
1.65e-07 |
4.241e-06 |
181 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
6 |
63 |
1.648e-07 |
4.241e-06 |
182 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
14 |
643 |
1.678e-07 |
4.289e-06 |
183 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
9 |
218 |
1.75e-07 |
4.45e-06 |
184 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
10 |
289 |
1.798e-07 |
4.547e-06 |
185 |
NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
6 |
64 |
1.812e-07 |
4.558e-06 |
186 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
17 |
983 |
1.829e-07 |
4.576e-06 |
187 |
LOCOMOTION |
18 |
1114 |
2.046e-07 |
5.091e-06 |
188 |
REGULATION OF TRANSPORT |
23 |
1804 |
2.123e-07 |
5.254e-06 |
189 |
REGULATION OF CELL CYCLE PROCESS |
13 |
558 |
2.265e-07 |
5.576e-06 |
190 |
CELL DEATH |
17 |
1001 |
2.366e-07 |
5.793e-06 |
191 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
21 |
1527 |
2.4e-07 |
5.816e-06 |
192 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
67 |
2.39e-07 |
5.816e-06 |
193 |
REGULATION OF MITOTIC CELL CYCLE |
12 |
468 |
2.511e-07 |
6.053e-06 |
194 |
VASCULATURE DEVELOPMENT |
12 |
469 |
2.569e-07 |
6.161e-06 |
195 |
EAR MORPHOGENESIS |
7 |
112 |
2.721e-07 |
6.493e-06 |
196 |
RESPONSE TO HORMONE |
16 |
893 |
2.786e-07 |
6.613e-06 |
197 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
8 |
167 |
2.851e-07 |
6.733e-06 |
198 |
REGULATION OF STEM CELL DIFFERENTIATION |
7 |
113 |
2.892e-07 |
6.796e-06 |
199 |
NEURAL PRECURSOR CELL PROLIFERATION |
6 |
70 |
3.111e-07 |
7.228e-06 |
200 |
APPENDAGE DEVELOPMENT |
8 |
169 |
3.122e-07 |
7.228e-06 |
201 |
LIMB DEVELOPMENT |
8 |
169 |
3.122e-07 |
7.228e-06 |
202 |
RESPONSE TO INORGANIC SUBSTANCE |
12 |
479 |
3.218e-07 |
7.412e-06 |
203 |
RESPONSE TO ABIOTIC STIMULUS |
17 |
1024 |
3.259e-07 |
7.47e-06 |
204 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
14 |
684 |
3.547e-07 |
8.091e-06 |
205 |
CELLULAR RESPONSE TO STRESS |
21 |
1565 |
3.613e-07 |
8.16e-06 |
206 |
MESENCHYME MORPHOGENESIS |
5 |
38 |
3.596e-07 |
8.16e-06 |
207 |
GLAND DEVELOPMENT |
11 |
395 |
3.688e-07 |
8.291e-06 |
208 |
REGULATION OF CELL SUBSTRATE ADHESION |
8 |
173 |
3.733e-07 |
8.35e-06 |
209 |
PARAXIAL MESODERM DEVELOPMENT |
4 |
16 |
3.759e-07 |
8.369e-06 |
210 |
CELLULAR RESPONSE TO ACID CHEMICAL |
8 |
175 |
4.075e-07 |
9.028e-06 |
211 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
119 |
4.117e-07 |
9.079e-06 |
212 |
RESPONSE TO ACID CHEMICAL |
10 |
319 |
4.463e-07 |
9.796e-06 |
213 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
7 |
121 |
4.612e-07 |
1.003e-05 |
214 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
11 |
404 |
4.61e-07 |
1.003e-05 |
215 |
REGULATION OF ORGANELLE ORGANIZATION |
18 |
1178 |
4.658e-07 |
1.008e-05 |
216 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
4.901e-07 |
1.056e-05 |
217 |
CELL CYCLE |
19 |
1316 |
4.966e-07 |
1.065e-05 |
218 |
GROWTH |
11 |
410 |
5.332e-07 |
1.138e-05 |
219 |
HEAD DEVELOPMENT |
14 |
709 |
5.458e-07 |
1.154e-05 |
220 |
EYE DEVELOPMENT |
10 |
326 |
5.443e-07 |
1.154e-05 |
221 |
MACROMOLECULAR COMPLEX DISASSEMBLY |
8 |
182 |
5.491e-07 |
1.156e-05 |
222 |
REGULATION OF HYDROLASE ACTIVITY |
19 |
1327 |
5.637e-07 |
1.181e-05 |
223 |
LEUKOCYTE ACTIVATION |
11 |
414 |
5.868e-07 |
1.224e-05 |
224 |
RESPONSE TO CYTOKINE |
14 |
714 |
5.936e-07 |
1.233e-05 |
225 |
PERICARDIUM DEVELOPMENT |
4 |
18 |
6.283e-07 |
1.299e-05 |
226 |
LEUKOCYTE CELL CELL ADHESION |
9 |
255 |
6.553e-07 |
1.349e-05 |
227 |
TUBE FORMATION |
7 |
129 |
7.121e-07 |
1.46e-05 |
228 |
REGULATION OF JUN KINASE ACTIVITY |
6 |
81 |
7.444e-07 |
1.519e-05 |
229 |
REGULATION OF INTRACELLULAR TRANSPORT |
13 |
621 |
7.605e-07 |
1.545e-05 |
230 |
KIDNEY MORPHOGENESIS |
6 |
82 |
8.007e-07 |
1.62e-05 |
231 |
LYMPHOCYTE ACTIVATION |
10 |
342 |
8.416e-07 |
1.695e-05 |
232 |
REGULATION OF CELL ADHESION |
13 |
629 |
8.778e-07 |
1.761e-05 |
233 |
CONNECTIVE TISSUE DEVELOPMENT |
8 |
194 |
8.901e-07 |
1.778e-05 |
234 |
MESENCHYMAL CELL DIFFERENTIATION |
7 |
134 |
9.207e-07 |
1.831e-05 |
235 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
15 |
867 |
1.079e-06 |
2.137e-05 |
236 |
IMMUNE SYSTEM PROCESS |
23 |
1984 |
1.144e-06 |
2.256e-05 |
237 |
COCHLEA MORPHOGENESIS |
4 |
21 |
1.218e-06 |
2.391e-05 |
238 |
FOREBRAIN DEVELOPMENT |
10 |
357 |
1.241e-06 |
2.426e-05 |
239 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
8 |
203 |
1.252e-06 |
2.438e-05 |
240 |
RESPONSE TO ALCOHOL |
10 |
362 |
1.406e-06 |
2.726e-05 |
241 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
8 |
207 |
1.45e-06 |
2.799e-05 |
242 |
SKELETAL SYSTEM DEVELOPMENT |
11 |
455 |
1.478e-06 |
2.841e-05 |
243 |
REGULATION OF CELL PROJECTION ORGANIZATION |
12 |
558 |
1.606e-06 |
3.074e-05 |
244 |
CARTILAGE DEVELOPMENT |
7 |
147 |
1.715e-06 |
3.248e-05 |
245 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
10 |
370 |
1.711e-06 |
3.248e-05 |
246 |
CELLULAR COMPONENT MORPHOGENESIS |
15 |
900 |
1.717e-06 |
3.248e-05 |
247 |
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
7 |
148 |
1.795e-06 |
3.367e-05 |
248 |
PEPTIDYL SERINE MODIFICATION |
7 |
148 |
1.795e-06 |
3.367e-05 |
249 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
6 |
95 |
1.909e-06 |
3.568e-05 |
250 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
5 |
53 |
1.964e-06 |
3.655e-05 |
251 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
12 |
573 |
2.114e-06 |
3.918e-05 |
252 |
NEURON DEVELOPMENT |
13 |
687 |
2.335e-06 |
4.303e-05 |
253 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
7 |
154 |
2.34e-06 |
4.303e-05 |
254 |
IMMUNE SYSTEM DEVELOPMENT |
12 |
582 |
2.483e-06 |
4.548e-05 |
255 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
9 |
303 |
2.725e-06 |
4.973e-05 |
256 |
POSITIVE REGULATION OF TRANSPORT |
15 |
936 |
2.784e-06 |
5.059e-05 |
257 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
4 |
26 |
2.998e-06 |
5.428e-05 |
258 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
8 |
229 |
3.077e-06 |
5.507e-05 |
259 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
10 |
395 |
3.068e-06 |
5.507e-05 |
260 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
6 |
103 |
3.064e-06 |
5.507e-05 |
261 |
REGENERATION |
7 |
161 |
3.144e-06 |
5.605e-05 |
262 |
EPITHELIAL CELL DIFFERENTIATION |
11 |
495 |
3.33e-06 |
5.914e-05 |
263 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
16 |
1079 |
3.352e-06 |
5.931e-05 |
264 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
8 |
232 |
3.388e-06 |
5.972e-05 |
265 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
4 |
27 |
3.509e-06 |
6.147e-05 |
266 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
12 |
602 |
3.514e-06 |
6.147e-05 |
267 |
REGULATION OF FAT CELL DIFFERENTIATION |
6 |
106 |
3.622e-06 |
6.289e-05 |
268 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
6 |
106 |
3.622e-06 |
6.289e-05 |
269 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
16 |
1087 |
3.685e-06 |
6.375e-05 |
270 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
7 |
166 |
3.85e-06 |
6.635e-05 |
271 |
CELL CELL ADHESION |
12 |
608 |
3.889e-06 |
6.678e-05 |
272 |
EMBRYONIC DIGIT MORPHOGENESIS |
5 |
61 |
3.974e-06 |
6.773e-05 |
273 |
MUSCLE CELL DIFFERENTIATION |
8 |
237 |
3.967e-06 |
6.773e-05 |
274 |
DOPAMINERGIC NEURON DIFFERENTIATION |
4 |
28 |
4.081e-06 |
6.931e-05 |
275 |
REGULATION OF MAP KINASE ACTIVITY |
9 |
319 |
4.144e-06 |
7.012e-05 |
276 |
REGULATION OF PROTEIN BINDING |
7 |
168 |
4.167e-06 |
7.025e-05 |
277 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
9 |
321 |
4.36e-06 |
7.324e-05 |
278 |
POSITIVE REGULATION OF LOCOMOTION |
10 |
420 |
5.279e-06 |
8.836e-05 |
279 |
REGULATION OF GROWTH |
12 |
633 |
5.863e-06 |
9.736e-05 |
280 |
RESPONSE TO METAL ION |
9 |
333 |
5.868e-06 |
9.736e-05 |
281 |
MESODERM MORPHOGENESIS |
5 |
66 |
5.879e-06 |
9.736e-05 |
282 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
13 |
750 |
6.074e-06 |
0.0001002 |
283 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
14 |
872 |
6.147e-06 |
0.0001011 |
284 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
4 |
31 |
6.217e-06 |
0.0001019 |
285 |
SPECIFICATION OF SYMMETRY |
6 |
117 |
6.42e-06 |
0.0001041 |
286 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
6 |
117 |
6.42e-06 |
0.0001041 |
287 |
MAMMARY GLAND DEVELOPMENT |
6 |
117 |
6.42e-06 |
0.0001041 |
288 |
RESPONSE TO DRUG |
10 |
431 |
6.624e-06 |
0.000107 |
289 |
MUSCLE STRUCTURE DEVELOPMENT |
10 |
432 |
6.76e-06 |
0.0001085 |
290 |
MESODERM DEVELOPMENT |
6 |
118 |
6.743e-06 |
0.0001085 |
291 |
NEGATIVE REGULATION OF CELL CYCLE |
10 |
433 |
6.898e-06 |
0.0001103 |
292 |
MITOTIC CELL CYCLE |
13 |
766 |
7.623e-06 |
0.0001215 |
293 |
COVALENT CHROMATIN MODIFICATION |
9 |
345 |
7.802e-06 |
0.0001239 |
294 |
NEURON PROJECTION DEVELOPMENT |
11 |
545 |
8.3e-06 |
0.0001309 |
295 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
8 |
262 |
8.279e-06 |
0.0001309 |
296 |
BRAIN MORPHOGENESIS |
4 |
34 |
9.082e-06 |
0.0001428 |
297 |
SEX DIFFERENTIATION |
8 |
266 |
9.245e-06 |
0.0001448 |
298 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
14 |
905 |
9.378e-06 |
0.0001464 |
299 |
PROTEIN AUTOPHOSPHORYLATION |
7 |
192 |
1.001e-05 |
0.0001557 |
300 |
EAR DEVELOPMENT |
7 |
195 |
1.107e-05 |
0.0001717 |
301 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
7 |
197 |
1.183e-05 |
0.0001829 |
302 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
3 |
12 |
1.224e-05 |
0.0001886 |
303 |
NEGATIVE REGULATION OF BINDING |
6 |
131 |
1.229e-05 |
0.0001887 |
304 |
REGULATION OF BMP SIGNALING PATHWAY |
5 |
77 |
1.257e-05 |
0.0001924 |
305 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
10 |
465 |
1.283e-05 |
0.0001957 |
306 |
RENAL TUBULE DEVELOPMENT |
5 |
78 |
1.339e-05 |
0.0002036 |
307 |
SKELETAL SYSTEM MORPHOGENESIS |
7 |
201 |
1.348e-05 |
0.0002043 |
308 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
12 |
689 |
1.374e-05 |
0.0002076 |
309 |
HEMATOPOIETIC STEM CELL PROLIFERATION |
3 |
13 |
1.587e-05 |
0.0002382 |
310 |
COCHLEA DEVELOPMENT |
4 |
39 |
1.587e-05 |
0.0002382 |
311 |
REGULATION OF SYNAPTIC PLASTICITY |
6 |
140 |
1.794e-05 |
0.0002684 |
312 |
LEUKOCYTE DIFFERENTIATION |
8 |
292 |
1.815e-05 |
0.0002707 |
313 |
SKIN DEVELOPMENT |
7 |
211 |
1.845e-05 |
0.0002742 |
314 |
POSITIVE REGULATION OF OSSIFICATION |
5 |
84 |
1.923e-05 |
0.000285 |
315 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
1.943e-05 |
0.0002863 |
316 |
PLATELET ACTIVATION |
6 |
142 |
1.944e-05 |
0.0002863 |
317 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE |
3 |
14 |
2.014e-05 |
0.0002937 |
318 |
REGULATION OF MONOCYTE DIFFERENTIATION |
3 |
14 |
2.014e-05 |
0.0002937 |
319 |
CONVERGENT EXTENSION |
3 |
14 |
2.014e-05 |
0.0002937 |
320 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
6 |
144 |
2.105e-05 |
0.000306 |
321 |
MODULATION OF SYNAPTIC TRANSMISSION |
8 |
301 |
2.256e-05 |
0.0003271 |
322 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
4 |
43 |
2.353e-05 |
0.0003401 |
323 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
3 |
15 |
2.51e-05 |
0.0003616 |
324 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
4 |
44 |
2.581e-05 |
0.0003707 |
325 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
11 |
616 |
2.589e-05 |
0.0003707 |
326 |
PROTEIN COMPLEX BIOGENESIS |
15 |
1132 |
2.698e-05 |
0.0003828 |
327 |
MIDBRAIN DEVELOPMENT |
5 |
90 |
2.688e-05 |
0.0003828 |
328 |
PROTEIN COMPLEX ASSEMBLY |
15 |
1132 |
2.698e-05 |
0.0003828 |
329 |
HEMOSTASIS |
8 |
311 |
2.849e-05 |
0.000403 |
330 |
PALLIUM DEVELOPMENT |
6 |
153 |
2.964e-05 |
0.0004179 |
331 |
TELENCEPHALON DEVELOPMENT |
7 |
228 |
3.033e-05 |
0.0004264 |
332 |
PEPTIDYL THREONINE MODIFICATION |
4 |
46 |
3.084e-05 |
0.0004297 |
333 |
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY |
3 |
16 |
3.081e-05 |
0.0004297 |
334 |
CELLULAR COMPONENT DISASSEMBLY |
10 |
515 |
3.077e-05 |
0.0004297 |
335 |
CHROMOSOME ORGANIZATION |
14 |
1009 |
3.154e-05 |
0.0004368 |
336 |
NEPHRON EPITHELIUM DEVELOPMENT |
5 |
93 |
3.15e-05 |
0.0004368 |
337 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
6 |
156 |
3.306e-05 |
0.0004564 |
338 |
DIGESTIVE TRACT MORPHOGENESIS |
4 |
48 |
3.656e-05 |
0.0005033 |
339 |
REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
3 |
17 |
3.731e-05 |
0.0005105 |
340 |
ESTABLISHMENT OF TISSUE POLARITY |
3 |
17 |
3.731e-05 |
0.0005105 |
341 |
CELL CELL SIGNALING |
12 |
767 |
3.945e-05 |
0.0005383 |
342 |
POSITIVE REGULATION OF GROWTH |
7 |
238 |
3.986e-05 |
0.0005424 |
343 |
ACTIVATION OF IMMUNE RESPONSE |
9 |
427 |
4.201e-05 |
0.0005699 |
344 |
CELL PROJECTION ORGANIZATION |
13 |
902 |
4.254e-05 |
0.0005754 |
345 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
50 |
4.302e-05 |
0.0005802 |
346 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
5 |
100 |
4.467e-05 |
0.0005956 |
347 |
INOSITOL PHOSPHATE MEDIATED SIGNALING |
3 |
18 |
4.464e-05 |
0.0005956 |
348 |
UTERUS DEVELOPMENT |
3 |
18 |
4.464e-05 |
0.0005956 |
349 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
4.464e-05 |
0.0005956 |
350 |
CHROMATIN MODIFICATION |
10 |
539 |
4.519e-05 |
0.0006008 |
351 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
7 |
246 |
4.916e-05 |
0.0006498 |
352 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
5 |
102 |
4.912e-05 |
0.0006498 |
353 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
7 |
247 |
5.043e-05 |
0.0006642 |
354 |
CHROMATIN ORGANIZATION |
11 |
663 |
5.053e-05 |
0.0006642 |
355 |
REGULATION OF CIRCADIAN RHYTHM |
5 |
103 |
5.147e-05 |
0.0006728 |
356 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
5 |
103 |
5.147e-05 |
0.0006728 |
357 |
POSITIVE REGULATION OF PROTEIN IMPORT |
5 |
104 |
5.391e-05 |
0.0007026 |
358 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
4 |
53 |
5.421e-05 |
0.0007027 |
359 |
MESONEPHRIC TUBULE MORPHOGENESIS |
4 |
53 |
5.421e-05 |
0.0007027 |
360 |
COGNITION |
7 |
251 |
5.582e-05 |
0.0007214 |
361 |
CEREBRAL CORTEX DEVELOPMENT |
5 |
105 |
5.643e-05 |
0.0007274 |
362 |
STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
173 |
5.892e-05 |
0.0007569 |
363 |
FAT CELL DIFFERENTIATION |
5 |
106 |
5.905e-05 |
0.0007569 |
364 |
CELL CYCLE PHASE TRANSITION |
7 |
255 |
6.166e-05 |
0.0007882 |
365 |
TRACHEA DEVELOPMENT |
3 |
20 |
6.202e-05 |
0.0007906 |
366 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
5 |
108 |
6.456e-05 |
0.0008207 |
367 |
REGULATION OF CYTOKINE PRODUCTION |
10 |
563 |
6.505e-05 |
0.0008225 |
368 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
10 |
563 |
6.505e-05 |
0.0008225 |
369 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
4 |
56 |
6.74e-05 |
0.0008476 |
370 |
OUTFLOW TRACT MORPHOGENESIS |
4 |
56 |
6.74e-05 |
0.0008476 |
371 |
REGULATION OF OSSIFICATION |
6 |
178 |
6.901e-05 |
0.0008655 |
372 |
FORMATION OF PRIMARY GERM LAYER |
5 |
110 |
7.045e-05 |
0.0008812 |
373 |
MYOTUBE DIFFERENTIATION |
4 |
57 |
7.227e-05 |
0.0008992 |
374 |
APOPTOTIC MITOCHONDRIAL CHANGES |
4 |
57 |
7.227e-05 |
0.0008992 |
375 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
7 |
263 |
7.486e-05 |
0.0009288 |
376 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
7.676e-05 |
0.0009499 |
377 |
REGULATION OF SECRETION |
11 |
699 |
8.115e-05 |
0.001002 |
378 |
MACROMOLECULAR COMPLEX ASSEMBLY |
16 |
1398 |
8.194e-05 |
0.001009 |
379 |
SOMATIC STEM CELL DIVISION |
3 |
22 |
8.331e-05 |
0.001023 |
380 |
POSITIVE REGULATION OF PROTEOLYSIS |
8 |
363 |
8.456e-05 |
0.001035 |
381 |
BLOOD VESSEL MORPHOGENESIS |
8 |
364 |
8.619e-05 |
0.001053 |
382 |
NEPHRON DEVELOPMENT |
5 |
115 |
8.702e-05 |
0.001057 |
383 |
RESPONSE TO CALCIUM ION |
5 |
115 |
8.702e-05 |
0.001057 |
384 |
NEGATIVE REGULATION OF CELL DIVISION |
4 |
60 |
8.843e-05 |
0.001072 |
385 |
CELL MOTILITY |
12 |
835 |
8.911e-05 |
0.001074 |
386 |
LOCALIZATION OF CELL |
12 |
835 |
8.911e-05 |
0.001074 |
387 |
PROTEASOMAL PROTEIN CATABOLIC PROCESS |
7 |
271 |
9.028e-05 |
0.001085 |
388 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
8 |
368 |
9.297e-05 |
0.001115 |
389 |
SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
3 |
23 |
9.553e-05 |
0.001143 |
390 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
6 |
191 |
0.0001018 |
0.001215 |
391 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
8 |
375 |
0.0001059 |
0.001257 |
392 |
REGULATION OF CHROMOSOME ORGANIZATION |
7 |
278 |
0.0001058 |
0.001257 |
393 |
REGULATION OF DENDRITE DEVELOPMENT |
5 |
120 |
0.0001064 |
0.00126 |
394 |
REGULATION OF EPIDERMIS DEVELOPMENT |
4 |
63 |
0.0001071 |
0.001261 |
395 |
REGULATION OF MUSCLE ADAPTATION |
4 |
63 |
0.0001071 |
0.001261 |
396 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
3 |
24 |
0.0001089 |
0.001276 |
397 |
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION |
3 |
24 |
0.0001089 |
0.001276 |
398 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
11 |
724 |
0.0001108 |
0.001292 |
399 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
5 |
121 |
0.0001107 |
0.001292 |
400 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
5 |
122 |
0.0001151 |
0.001338 |
401 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
5 |
123 |
0.0001196 |
0.001384 |
402 |
T CELL DIFFERENTIATION |
5 |
123 |
0.0001196 |
0.001384 |
403 |
LENS FIBER CELL DIFFERENTIATION |
3 |
25 |
0.0001234 |
0.001421 |
404 |
SPINDLE CHECKPOINT |
3 |
25 |
0.0001234 |
0.001421 |
405 |
REPRODUCTION |
15 |
1297 |
0.0001265 |
0.001454 |
406 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
6 |
199 |
0.0001275 |
0.001461 |
407 |
CELLULAR RESPONSE TO UV |
4 |
66 |
0.0001284 |
0.001464 |
408 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
4 |
66 |
0.0001284 |
0.001464 |
409 |
RESPONSE TO STEROID HORMONE |
9 |
497 |
0.0001339 |
0.00152 |
410 |
REGULATION OF DEVELOPMENTAL GROWTH |
7 |
289 |
0.0001346 |
0.00152 |
411 |
APOPTOTIC SIGNALING PATHWAY |
7 |
289 |
0.0001346 |
0.00152 |
412 |
RESPONSE TO UV |
5 |
126 |
0.0001339 |
0.00152 |
413 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
4 |
67 |
0.0001362 |
0.00153 |
414 |
REGULATION OF SISTER CHROMATID SEGREGATION |
4 |
67 |
0.0001362 |
0.00153 |
415 |
REGULATION OF CELL GROWTH |
8 |
391 |
0.0001412 |
0.001583 |
416 |
REGULATION OF PHOSPHATASE ACTIVITY |
5 |
128 |
0.0001442 |
0.00161 |
417 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
4 |
68 |
0.0001442 |
0.00161 |
418 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
6 |
204 |
0.0001459 |
0.001625 |
419 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
5 |
129 |
0.0001496 |
0.001661 |
420 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
9 |
505 |
0.000151 |
0.001673 |
421 |
REGULATION OF BODY FLUID LEVELS |
9 |
506 |
0.0001533 |
0.001694 |
422 |
SKELETAL MUSCLE TISSUE REGENERATION |
3 |
27 |
0.000156 |
0.001712 |
423 |
REGULATION OF LAMELLIPODIUM ASSEMBLY |
3 |
27 |
0.000156 |
0.001712 |
424 |
RESPONSE TO LITHIUM ION |
3 |
27 |
0.000156 |
0.001712 |
425 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
6 |
207 |
0.000158 |
0.00173 |
426 |
PROTEIN LOCALIZATION |
18 |
1805 |
0.0001598 |
0.001745 |
427 |
LYMPHOCYTE DIFFERENTIATION |
6 |
209 |
0.0001665 |
0.001814 |
428 |
NEURON PROJECTION MORPHOGENESIS |
8 |
402 |
0.0001707 |
0.001856 |
429 |
GASTRULATION WITH MOUTH FORMING SECOND |
3 |
28 |
0.0001743 |
0.001877 |
430 |
NEGATIVE REGULATION OF CHROMOSOME SEGREGATION |
3 |
28 |
0.0001743 |
0.001877 |
431 |
NEGATIVE REGULATION OF DENDRITE DEVELOPMENT |
3 |
28 |
0.0001743 |
0.001877 |
432 |
MORPHOGENESIS OF A POLARIZED EPITHELIUM |
3 |
28 |
0.0001743 |
0.001877 |
433 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
7 |
303 |
0.00018 |
0.001935 |
434 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
8 |
408 |
0.0001888 |
0.002024 |
435 |
PANCREAS DEVELOPMENT |
4 |
73 |
0.00019 |
0.002032 |
436 |
STEM CELL DIVISION |
3 |
29 |
0.0001938 |
0.002068 |
437 |
HINDBRAIN DEVELOPMENT |
5 |
137 |
0.0001981 |
0.00211 |
438 |
REGULATION OF DENDRITE MORPHOGENESIS |
4 |
74 |
0.0002002 |
0.002127 |
439 |
RESPONSE TO OXYGEN LEVELS |
7 |
311 |
0.0002112 |
0.002233 |
440 |
NEURAL CREST CELL DIFFERENTIATION |
4 |
75 |
0.0002109 |
0.002233 |
441 |
REGULATION OF CELLULAR RESPONSE TO HEAT |
4 |
76 |
0.0002219 |
0.002342 |
442 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
5 |
141 |
0.0002265 |
0.002385 |
443 |
DIENCEPHALON DEVELOPMENT |
4 |
77 |
0.0002334 |
0.002452 |
444 |
SYNAPTIC SIGNALING |
8 |
424 |
0.000245 |
0.002567 |
445 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
9 |
541 |
0.000252 |
0.002629 |
446 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
9 |
541 |
0.000252 |
0.002629 |
447 |
NEGATIVE REGULATION OF PROTEIN BINDING |
4 |
79 |
0.0002576 |
0.002682 |
448 |
RESPONSE TO ESTRADIOL |
5 |
146 |
0.0002663 |
0.002766 |
449 |
REGULATION OF GTPASE ACTIVITY |
10 |
673 |
0.0002784 |
0.002886 |
450 |
REGULATION OF FIBROBLAST PROLIFERATION |
4 |
81 |
0.0002836 |
0.002926 |
451 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
4 |
81 |
0.0002836 |
0.002926 |
452 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
9 |
552 |
0.0002922 |
0.003008 |
453 |
NEGATIVE REGULATION OF PROTEOLYSIS |
7 |
329 |
0.0002972 |
0.003047 |
454 |
JNK CASCADE |
4 |
82 |
0.0002973 |
0.003047 |
455 |
REGULATION OF NEURON DIFFERENTIATION |
9 |
554 |
0.0003001 |
0.003069 |
456 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
3 |
34 |
0.000313 |
0.00318 |
457 |
NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
3 |
34 |
0.000313 |
0.00318 |
458 |
NEURAL TUBE PATTERNING |
3 |
34 |
0.000313 |
0.00318 |
459 |
NEGATIVE REGULATION OF GROWTH |
6 |
236 |
0.0003203 |
0.003247 |
460 |
CELL CYCLE ARREST |
5 |
154 |
0.0003406 |
0.003431 |
461 |
AMEBOIDAL TYPE CELL MIGRATION |
5 |
154 |
0.0003406 |
0.003431 |
462 |
REGULATION OF CHROMOSOME SEGREGATION |
4 |
85 |
0.0003411 |
0.003431 |
463 |
BONE REMODELING |
3 |
35 |
0.0003414 |
0.003431 |
464 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
5 |
156 |
0.0003614 |
0.003616 |
465 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
5 |
156 |
0.0003614 |
0.003616 |
466 |
HEAD MORPHOGENESIS |
3 |
36 |
0.0003714 |
0.003708 |
467 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
14 |
1275 |
0.0003734 |
0.00372 |
468 |
REGULATION OF DEPHOSPHORYLATION |
5 |
158 |
0.0003832 |
0.00381 |
469 |
REGULATION OF STEM CELL PROLIFERATION |
4 |
88 |
0.0003894 |
0.003863 |
470 |
PEPTIDYL AMINO ACID MODIFICATION |
11 |
841 |
0.0004036 |
0.003979 |
471 |
REGULATION OF MUSCLE HYPERTROPHY |
3 |
37 |
0.000403 |
0.003979 |
472 |
REGULATION OF LAMELLIPODIUM ORGANIZATION |
3 |
37 |
0.000403 |
0.003979 |
473 |
CELL DIVISION |
8 |
460 |
0.0004224 |
0.004156 |
474 |
REGULATION OF CELL MATRIX ADHESION |
4 |
90 |
0.0004242 |
0.004164 |
475 |
SYSTEM PROCESS |
17 |
1785 |
0.0004337 |
0.004248 |
476 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
3 |
38 |
0.0004363 |
0.004265 |
477 |
REGULATION OF NUCLEAR DIVISION |
5 |
163 |
0.0004419 |
0.004306 |
478 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
4 |
91 |
0.0004424 |
0.004306 |
479 |
TAXIS |
8 |
464 |
0.0004474 |
0.004346 |
480 |
CELL SUBSTRATE ADHESION |
5 |
164 |
0.0004544 |
0.004405 |
481 |
REGULATION OF EPITHELIAL CELL MIGRATION |
5 |
166 |
0.0004803 |
0.004646 |
482 |
REGULATION OF INNATE IMMUNE RESPONSE |
7 |
357 |
0.0004851 |
0.004683 |
483 |
REGULATION OF MEIOTIC CELL CYCLE |
3 |
40 |
0.0005081 |
0.004855 |
484 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
3 |
40 |
0.0005081 |
0.004855 |
485 |
RESPONSE TO CARBOHYDRATE |
5 |
168 |
0.0005072 |
0.004855 |
486 |
HINDBRAIN MORPHOGENESIS |
3 |
40 |
0.0005081 |
0.004855 |
487 |
REGULATION OF AXONOGENESIS |
5 |
168 |
0.0005072 |
0.004855 |
488 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
4 |
95 |
0.0005208 |
0.004966 |
489 |
NEGATIVE REGULATION OF CELL GROWTH |
5 |
170 |
0.0005353 |
0.005093 |
490 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
4 |
96 |
0.0005418 |
0.005145 |
491 |
REGULATION OF HORMONE LEVELS |
8 |
478 |
0.0005442 |
0.005149 |
492 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
7 |
364 |
0.0005444 |
0.005149 |
493 |
REGULATION OF HORMONE SECRETION |
6 |
262 |
0.0005572 |
0.005259 |
494 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
9 |
606 |
0.0005751 |
0.005417 |
495 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
3 |
42 |
0.0005871 |
0.005508 |
496 |
GENITALIA DEVELOPMENT |
3 |
42 |
0.0005871 |
0.005508 |
497 |
HOMEOSTATIC PROCESS |
14 |
1337 |
0.0006006 |
0.0056 |
498 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
7 |
370 |
0.0005998 |
0.0056 |
499 |
POSITIVE REGULATION OF SECRETION |
7 |
370 |
0.0005998 |
0.0056 |
500 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
4 |
99 |
0.0006086 |
0.005652 |
501 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
4 |
99 |
0.0006086 |
0.005652 |
502 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
3 |
43 |
0.0006294 |
0.005834 |
503 |
METENCEPHALON DEVELOPMENT |
4 |
100 |
0.0006321 |
0.005847 |
504 |
POSITIVE REGULATION OF CELL ADHESION |
7 |
376 |
0.0006595 |
0.006089 |
505 |
BODY MORPHOGENESIS |
3 |
44 |
0.0006736 |
0.006206 |
506 |
REGULATION OF CELL DIVISION |
6 |
272 |
0.0006779 |
0.006234 |
507 |
REGULATION OF CHEMOTAXIS |
5 |
180 |
0.0006934 |
0.006364 |
508 |
REGULATION OF CELL CELL ADHESION |
7 |
380 |
0.0007019 |
0.006429 |
509 |
REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS |
4 |
103 |
0.0007064 |
0.006458 |
510 |
REGULATION OF DEFENSE RESPONSE |
10 |
759 |
0.0007137 |
0.006511 |
511 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
4 |
104 |
0.0007325 |
0.00667 |
512 |
SINGLE ORGANISM BEHAVIOR |
7 |
384 |
0.0007464 |
0.006776 |
513 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
5 |
183 |
0.0007471 |
0.006776 |
514 |
NEGATIVE REGULATION OF DNA BINDING |
3 |
46 |
0.0007677 |
0.006936 |
515 |
NEGATIVE REGULATION OF NUCLEAR DIVISION |
3 |
46 |
0.0007677 |
0.006936 |
516 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
6 |
279 |
0.0007739 |
0.006979 |
517 |
CELL PART MORPHOGENESIS |
9 |
633 |
0.0007845 |
0.007047 |
518 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
5 |
185 |
0.0007845 |
0.007047 |
519 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
6 |
280 |
0.0007884 |
0.007055 |
520 |
RESPONSE TO LIGHT STIMULUS |
6 |
280 |
0.0007884 |
0.007055 |
521 |
EPITHELIAL CELL DEVELOPMENT |
5 |
186 |
0.0008038 |
0.007154 |
522 |
PRIMITIVE STREAK FORMATION |
2 |
11 |
0.0008072 |
0.007154 |
523 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
2 |
11 |
0.0008072 |
0.007154 |
524 |
OLFACTORY BULB INTERNEURON DEVELOPMENT |
2 |
11 |
0.0008072 |
0.007154 |
525 |
POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS |
2 |
11 |
0.0008072 |
0.007154 |
526 |
MUSCLE FIBER DEVELOPMENT |
3 |
47 |
0.0008178 |
0.007234 |
527 |
RESPONSE TO HYDROGEN PEROXIDE |
4 |
109 |
0.0008734 |
0.007711 |
528 |
PROTEIN DEPHOSPHORYLATION |
5 |
190 |
0.0008843 |
0.007793 |
529 |
BEHAVIOR |
8 |
516 |
0.0008954 |
0.007876 |
530 |
REGULATION OF NEURONAL SYNAPTIC PLASTICITY |
3 |
49 |
0.000924 |
0.008097 |
531 |
CELLULAR RESPONSE TO CALCIUM ION |
3 |
49 |
0.000924 |
0.008097 |
532 |
POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
5 |
192 |
0.0009267 |
0.008105 |
533 |
KERATINOCYTE PROLIFERATION |
2 |
12 |
0.0009662 |
0.008341 |
534 |
POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION |
2 |
12 |
0.0009662 |
0.008341 |
535 |
CARTILAGE MORPHOGENESIS |
2 |
12 |
0.0009662 |
0.008341 |
536 |
ROSTROCAUDAL NEURAL TUBE PATTERNING |
2 |
12 |
0.0009662 |
0.008341 |
537 |
TRACHEA MORPHOGENESIS |
2 |
12 |
0.0009662 |
0.008341 |
538 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
2 |
12 |
0.0009662 |
0.008341 |
539 |
LENS FIBER CELL DEVELOPMENT |
2 |
12 |
0.0009662 |
0.008341 |
540 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
3 |
50 |
0.0009802 |
0.008431 |
541 |
FACE DEVELOPMENT |
3 |
50 |
0.0009802 |
0.008431 |
542 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
5 |
195 |
0.0009932 |
0.008526 |
543 |
ANGIOGENESIS |
6 |
293 |
0.0009971 |
0.008544 |
544 |
REGULATION OF SYNAPSE ORGANIZATION |
4 |
113 |
0.000999 |
0.008545 |
545 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
4 |
114 |
0.001032 |
0.008813 |
546 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
3 |
51 |
0.001039 |
0.008842 |
547 |
RESPIRATORY SYSTEM DEVELOPMENT |
5 |
197 |
0.001039 |
0.008842 |
548 |
RESPONSE TO INTERLEUKIN 1 |
4 |
115 |
0.001066 |
0.009054 |
549 |
TISSUE REGENERATION |
3 |
52 |
0.001099 |
0.009315 |
550 |
RESPONSE TO RADIATION |
7 |
413 |
0.00114 |
0.009629 |
551 |
REGULATION OF SKELETAL MUSCLE ADAPTATION |
2 |
13 |
0.001139 |
0.009629 |
552 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
3 |
53 |
0.001162 |
0.009793 |